Why Is Aging Conserved and What Can We Do about It?

PLoS Biology

Volumn 13, Issue 4, 2015, Pages

  Pitt, Jason N ^a   Kaeberlein, Matt ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; SOMATOMEDIN C;

AGING; BODY SIZE; DOG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; HEALTH PROMOTION; HEALTH STATUS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LIFE EXPECTANCY; LIFESPAN; LONGEVITY; NONHUMAN; NOTE; QUALITY OF LIFE; RNA TRANSLATION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; ANIMAL; RESEARCH;

MAMMALIA;

AGING; ANIMALS; HUMANS; RESEARCH;

EID: 84929493833     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1002131     Document Type: Note

References (78)

1. Coles LS, (2004) Demography of human supercentenarians. J Gerontol A Biol Sci Med Sci 59: B579–586. 15215268
2. Promislow DE, (1993) On size and survival: progress and pitfalls in the allometry of life span. J Gerontol 48: B115–123. 8315214
3. Buffenstein R, (2008) Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species. J Comp Physiol B 178: 439–445. doi: 10.1007/s00360-007-0237-5 18180931
4. Philipp EE, Abele D, (2010) Masters of longevity: lessons from long-lived bivalves—a mini-review. Gerontology 56: 55–65. doi: 10.1159/000221004 19468199
5. Finch CE, (2009) Update on slow aging and negligible senescence—a mini-review. Gerontology 55: 307–313. doi: 10.1159/000215589 19439974
6. Sutter NB, Bustamante CD, Chase K, Gray MM, Zhao K, et al. (2007) A single IGF1 allele is a major determinant of small size in dogs. Science 316: 112–115. 17412960
7. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, et al. (2011) Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med 3: 70ra13. doi: 10.1126/scitranslmed.3001845 21325617
8. Lin SJ, Defossez PA, Guarente L, (2000) Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126–2128. 11000115
9. Smith ED, Kaeberlein TL, Lydum BT, Sager J, Welton KL, et al. (2008) Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans. BMC Dev Biol 8: 49. doi: 10.1186/1471-213X-8-49 18457595
10. Weindruch R, Walford RL, Fligiel S, Guthrie D, (1986) The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr 116: 641–654. 3958810
11. Mair W, Goymer P, Pletcher SD, Partridge L, (2003) Demography of dietary restriction and death in Drosophila. Science 301: 1731–1733. 14500985
12. Holloszy JO, Fontana L, (2007) Caloric restriction in humans. Exp Gerontol 42: 709–712. 17482403
13. MacLean M, Harris N, Piper PW, (2001) Chronological lifespan of stationary phase yeast cells; a model for investigating the factors that might influence the ageing of postmitotic tissues in higher organisms. Yeast 18: 499–509. 11284006
14. Leiser SF, Begun A, Kaeberlein M, (2011) HIF-1 modulates longevity and healthspan in a temperature-dependent manner. Aging Cell 10: 318–326. doi: 10.1111/j.1474-9726.2011.00672.x 21241450
15. Sestini EA, Carlson JC, Allsopp R, (1991) The effects of ambient temperature on life span, lipid peroxidation, superoxide dismutase, and phospholipase A2 activity in Drosophila melanogaster. Exp Gerontol 26: 385–395. 1936197
16. Conti B, Sanchez-Alavez M, Winsky-Sommerer R, Morale MC, Lucero J, et al. (2006) Transgenic mice with a reduced core body temperature have an increased life span. Science 314: 825–828. 17082459
17. Leiser SF, Fletcher M, Begun A, Kaeberlein M, (2013) Life-span extension from hypoxia in Caenorhabditis elegans requires both HIF-1 and DAF-16 and is antagonized by SKN-1. J Gerontol A Biol Sci Med Sci 68: 1135–1144. doi: 10.1093/gerona/glt016 23419779
18. Rascon B, Harrison JF, (2010) Lifespan and oxidative stress show a non-linear response to atmospheric oxygen in Drosophila. J Exp Biol 213: 3441–3448. doi: 10.1242/jeb.044867 20889824
19. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD, (2001) Regulation of longevity and stress resistance by Sch9 in yeast. Science 292: 288–290. 11292860
20. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R, (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366: 461–464. 8247153
21. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, et al. (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104–106. 11292874
22. Anisimov VN, Bartke A, (2013) The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer. Crit Rev Oncol Hematol 87: 201–223. doi: 10.1016/j.critrevonc.2013.01.005 23434537
23. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, et al. (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A 105: 3438–3442. doi: 10.1073/pnas.0705467105 18316725
24. Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, et al. (2008) FOXO3A genotype is strongly associated with human longevity. Proceedings of the National Academy of Sciences of the United States of America 105: 13987–13992. doi: 10.1073/pnas.0801030105 18765803
25. Kaeberlein M, Powers RW, 3rdSteffen KK, Westman EA, Hu D, et al. (2005) Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310: 1193–1196. 16293764
26. Powers RW, 3rdKaeberlein M, Caldwell SD, Kennedy BK, Fields S, (2006) Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev 20: 174–184. 16418483
27. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, et al. (2003) Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426: 620. 14668851
28. Robida-Stubbs S, Glover-Cutter K, Lamming DW, Mizunuma M, Narasimhan SD, et al. (2012) TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell metabolism 15: 713–724. doi: 10.1016/j.cmet.2012.04.007 22560223
29. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, et al. (2004) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 14: 885–890. 15186745
30. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, et al. (2010) Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 11: 35–46. doi: 10.1016/j.cmet.2009.11.010 20074526
31. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392–395. doi: 10.1038/nature08221 19587680
32. Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, et al. (2013) Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep 4: 913–920. doi: 10.1016/j.celrep.2013.07.030 23994476
33. Passtoors WM, Beekman M, Deelen J, van der Breggen R, Maier AB, et al. (2013) Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 12: 24–31. doi: 10.1111/acel.12015 23061800
34. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, et al. (2014) mTOR inhibition improves immune function in the elderly. Sci Transl Med 6: 268ra179. doi: 10.1126/scitranslmed.3009892 25540326
35. Lu JY, Lin YY, Sheu JC, Wu JT, Lee FJ, et al. (2011) Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction. Cell 146: 969–979. doi: 10.1016/j.cell.2011.07.044 21906795
36. Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R, (2004) The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18: 3004–3009. 15574588
37. Slack C, Foley A, Partridge L, (2012) Activation of AMPK by the putative dietary restriction mimetic metformin is insufficient to extend lifespan in Drosophila. PLoS ONE 7: e47699. doi: 10.1371/journal.pone.0047699 23077661
38. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, et al. (2013) Metformin improves healthspan and lifespan in mice. Nat Commun 4: 2192. doi: 10.1038/ncomms3192 23900241
39. Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, et al. (2014) Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 16: 1165–1173. doi: 10.1111/dom.12354 25041462
40. Onken B, Driscoll M, (2010) Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PloS ONE 5: e8758. doi: 10.1371/journal.pone.0008758 20090912
41. Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, et al. (2013) Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 18: 416–430. doi: 10.1016/j.cmet.2013.07.013 24011076
42. Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, et al. (2012) The sirtuin SIRT6 regulates lifespan in male mice. Nature 483: 218–221. doi: 10.1038/nature10815 22367546
43. Rogina B, Helfand SL, (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101: 15998–16003. 15520384
44. Tissenbaum HA, Guarente L, (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227–230. 11242085
45. Kaeberlein M, McVey M, Guarente L, (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13: 2570–2580. 10521401
46. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, et al. (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85: 258–263. 15676284
47. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, et al. (2005) Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308: 1909–1911. 15879174
48. Orr WC, Sohal RS, (1994) Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263: 1128–1130. 8108730
49. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, et al. (2000) Extension of life-span with superoxide dismutase/catalase mimetics. Science 289: 1567–1569. 10968795
50. Kaeberlein M, (2013) Longevity and aging. F1000Prime Rep 5: 5. doi: 10.12703/P5-5 23513177
51. Omodei D, Fontana L, (2011) Calorie restriction and prevention of age-associated chronic disease. FEBS letters 585: 1537–1542. doi: 10.1016/j.febslet.2011.03.015 21402069
52. Anderson RM, Weindruch R, (2012) The caloric restriction paradigm: implications for healthy human aging. Am J Hum Biol 24: 101–106. doi: 10.1002/ajhb.22243 22290875
53. Johnson SC, Rabinovitch PS, Kaeberlein M, (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493: 338–345. doi: 10.1038/nature11861 23325216
54. Kenyon CJ, (2010) The genetics of ageing. Nature 464: 504–512. doi: 10.1038/nature08980 20336132
55. Kirkwood TB, (2005) Understanding the odd science of aging. Cell 120: 437–447. 15734677
56. Flatt T, (2011) Survival costs of reproduction in Drosophila. Exp Gerontol 46: 369–375. doi: 10.1016/j.exger.2010.10.008 20970491
57. Giannakou ME, Goss M, Jacobson J, Vinti G, Leevers SJ, et al. (2007) Dynamics of the action of dFOXO on adult mortality in Drosophila. Aging Cell 6: 429–438. 17465980
58. Linford NJ, Kuo TH, Chan TP, Pletcher SD, (2011) Sensory perception and aging in model systems: from the outside in. Annu Rev Cell Dev Biol 27: 759–785. doi: 10.1146/annurev-cellbio-092910-154240 21756108
59. Blagosklonny MV, (2006) Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell cycle 5: 2087–2102. 17012837
60. Gems D, Partridge L, (2013) Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol 75: 621–644. doi: 10.1146/annurev-physiol-030212-183712 23190075
61. Blagosklonny MV, (2013) Aging is not programmed: genetic pseudo-program is a shadow of developmental growth. Cell Cycle 12: 3736–3742. doi: 10.4161/cc.27188 24240128
62. Kirkwood TB, Melov S, (2011) On the programmed/non-programmed nature of ageing within the life history. Curr Biol 21: R701–707. doi: 10.1016/j.cub.2011.07.020 21959160
63. Mather KA, Jorm AF, Parslow RA, Christensen H, (2011) Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci 66: 202–213. doi: 10.1093/gerona/glq180 21030466
64. Boonekamp JJ, Simons MJ, Hemerik L, Verhulst S, (2013) Telomere length behaves as biomarker of somatic redundancy rather than biological age. Aging Cell 12: 330–332. doi: 10.1111/acel.12050 23346961
65. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G, (2013) The hallmarks of aging. Cell 153: 1194–1217. doi: 10.1016/j.cell.2013.05.039 23746838
66. Butler RN, Sprott R, Warner H, Bland J, Feuers R, et al. (2004) Biomarkers of aging: from primitive organisms to humans. J Gerontol A Biol Sci Med Sci 59: B560–567. 15215265
67. Hou L, Huang J, Green CD, Boyd-Kirkup J, Zhang W, et al. (2012) Systems biology in aging: linking the old and the young. Curr Genomics 13: 558–565. doi: 10.2174/138920212803251418 23633915
68. Sanders JL, Newman AB, (2013) Telomere Length in Epidemiology: A Biomarker of Aging, Age-Related Disease, Both, or Neither? Epidemiol Rev. doi: 10.1093/epirev/mxt011 24363355
69. Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, et al. (2015) DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 16: 25. 25633388
70. Johnson SC, Martin GM, Rabinovitch PS, Kaeberlein M, (2013) Preserving youth: does rapamycin deliver? Sci Transl Med 5: 211fs240. doi: 10.1126/scitranslmed.3007316 24225941
71. Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R, et al. (2014) Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun 5: 3557. doi: 10.1038/ncomms4557 24691430
72. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, et al. (2005) Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2: 8. 15904534
73. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, et al. (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8: 18–30. doi: 10.1016/j.arr.2008.07.002 18692159
74. Fries JF, Bruce B, Chakravarty E, (2011) Compression of morbidity 1980–2011: a focused review of paradigms and progress. J Aging Res 2011: 261702. doi: 10.4061/2011/261702 21876805
75. Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, et al. (2013) Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 32: 1698–1705. doi: 10.1377/hlthaff.2013.0052 24101058
76. Holzenberger M, (2011) Igf-I signaling and effects on longevity. Nestle Nutr Workshop Ser Pediatr Program 68: 237–245; discussion 246–239. doi: 10.1159/000325914 22044904
77. Chen C, Liu Y, Zheng P, (2009) mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2: ra75. doi: 10.1126/scisignal.2000559 19934433
78. Fleming JM, Creevy KE, Promislow DE, (2011) Mortality in north american dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death. J Vet Intern Med 25: 187–198. doi: 10.1111/j.1939-1676.2011.0695.x 21352376